pamidronate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pao, VY | 1 |
| Chang, S | 1 |
| Shoback, DM | 1 |
| Bikle, DD | 1 |
| Silva, KL | 1 |
| Vasconcellos, DV | 1 |
| Castro, ED | 1 |
| Vasconcelos, FC | 1 |
| Bigni, R | 1 |
| Maia, RC | 1 |
2 other studies available for pamidronate and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Aged; Diphosphonates; Humans; Hypercalcemia; Leukemia, Lym | 2009 |
Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2008 |